New overseas treatment PMI product unveiled
Passport2Health has launched a private medical insurance (PMI) product to enable policyholders to undergo treatment abroad.
The provider said the product, which will be available through selected PMI specialists and insurance brokers, as well as directly via the internet, will allow UK patients to combine private diagnostics in the UK with private treatment overseas.
The product is designed to cover patients seeking elective treatments such as angioplasty, hernias, hip replacements or cataracts. Customers will have the same access to their usual GP, plus an allowance for private specialist consultations and
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.
You are currently unable to print this content. Please contact info@insuranceage.co.uk to find out more.
You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@insuranceage.co.uk
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@insuranceage.co.uk
Most read
- Zurich strikes five-year capacity deal with MGA Freedom Services
- Pen inks £150m social housing capacity deal with SiriusPoint
- RSA and NIG brands to become one next year but undecided on name